Oxanobol 10 - SP Laboratory

Oxandrolone’s history began in 1962 with its creation by G.D. Searle & Co., which launched it as Anavar. It was developed for medical conditions requiring anabolic support with minimal androgenic side effects. The compound found global distribution under different trade names like Anatrophill, Protivar, and Lonavar. Due to the controversy surrounding anabolic steroids in competitive sports, Searle pulled Anavar from the market in 1989. It was later revived in 1995 as Oxandrin, produced by Bio-Technology General Corp., targeting serious wasting disorders and growth issues with FDA orphan drug designation.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Oxanobol 10 by SP Laboratory, consult with your doctor or healthcare professional.